| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_017825.3 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 54936 |
| UniProt ID | Q9NX46 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_017825.3 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 54936 |
| UniProt ID | Q9NX46 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADPRHL2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK7465MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK17213MR | IVTScrip™ mRNA-Human ALG13, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) | mRNA | ALG13 |
| GTTS-WK17841MR | IVTScrip™ mRNA-Human ALPP, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | ALPP |
| GTTS-WK12252MR | IVTScrip™ mRNA-Human ADI1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | ADI1 |
| GTTS-WK13356MR | IVTScrip™ mRNA-Human ACSS3, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) | mRNA | ACSS3 |
| GTTS-WK21448MR | IVTScrip™ mRNA-Human AMD1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | AMD1 |
| GTTS-WK22825MR | IVTScrip™ mRNA-Human APOBEC4, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | APOBEC4 |
| GTTS-WK3669MR | IVTScrip™ mRNA-Human CD220, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) | mRNA | CD220 |
| GTTS-WK12590MR | IVTScrip™ mRNA-Human AGAP6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | AGAP6 |